These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30944024)

  • 1. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA.
    Koenig C; Morgan J; Ammann RA; Sung L; Phillips B
    Syst Rev; 2019 Apr; 8(1):82. PubMed ID: 30944024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review.
    Koenig C; Schneider C; Morgan JE; Ammann RA; Sung L; Phillips B
    Support Care Cancer; 2020 May; 28(5):2369-2380. PubMed ID: 31486984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.
    Koenig C; Schneider C; Morgan JE; Ammann RA; Sung L; Phillips B
    Support Care Cancer; 2020 Mar; 28(3):1369-1383. PubMed ID: 31264188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia.
    Morgan JE; Stewart L; Phillips RS
    Syst Rev; 2014 Oct; 3():119. PubMed ID: 25336249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].
    Simon A; Lehrnbecher T; Baltaci Y; Dohna-Schwake C; Groll A; Laws HJ; Potratz J; Hufnagel M; Bochennek K
    Klin Padiatr; 2023 Nov; 235(6):331-341. PubMed ID: 37751768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer.
    Koenig C; Kuehni CE; Bodmer N; Agyeman PKA; Ansari M; Roessler J; von der Weid NX; Ammann RA
    Sci Rep; 2022 Aug; 12(1):14028. PubMed ID: 35982121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.
    Salstrom JL; Coughlin RL; Pool K; Bojan M; Mediavilla C; Schwent W; Rannie M; Law D; Finnerty M; Hilden J
    Pediatr Blood Cancer; 2015 May; 62(5):807-15. PubMed ID: 25663663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
    van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a Nursing Based Order Set: Improved Antibiotic Administration Times for Pediatric ED Patients with Therapy-Induced Neutropenia and Fever.
    Lukes T; Schjodt K; Struwe L
    J Pediatr Nurs; 2019; 46():78-82. PubMed ID: 30856462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
    van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
    Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia.
    Rosa RG; Goldani LZ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3799-803. PubMed ID: 24752269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever and neutropenia outcomes and areas for intervention: A report from SUCCOUR - Supportive Care for Children with Cancer in Africa.
    Israels T; Afungchwi GM; Klootwijk L; Njuguna F; Hesseling P; Kouya F; Paintsil V; Landman L; Chitsike I; Chagaluka G; Sung L; Molyneux E
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29224. PubMed ID: 34245212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
    Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.
    Clark OA; Lyman GH; Castro AA; Clark LG; Djulbegovic B
    J Clin Oncol; 2005 Jun; 23(18):4198-214. PubMed ID: 15961767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
    Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.